HCPLive

Hepatitis C

Latest Headlines

Hepatitis C: Experimental Anti-Viral Combo Helps Tough Cases
A new antiviral combination is showing promise in treating patients with both chronic kidney disease and chronic hepatitis C, Texas researchers reported at the International Liver Congress in Vienna, Austria.
Drug Combo Helps Hardest-to-Treat Liver Patients
Patients with severe cirrhosis, those who are waiting for a liver transplant, or have recurrent hepatitis C infection following treatment are desperately ill. Researchers at the 2015 International Liver Congress reported that a fixed dose combination of ledipasvir/sofosbuvir given in combination with ribavirin helped many of these patients, according to the results from the SOLAR 2 trial.
Researchers Force Viruses to Kill Themselves Via Mutation Rate
As immunity to antibiotics continues to be an issue in the world of viruses, researchers from the University of Chicago (UChicago) and the Massachusetts Institute of Technology (MIT) have found a way to force the stubborn pathogens to eliminate themselves.
Hepatitis C Behind Bars May Be Too Costly to Cure
A study of Rhode Island state prisons shines a spotlight on the trouble correctional facilities face because they aren’t financially equipped to bear the budget-busting costs of new drugs to treat all inmates chronically infected with hepatitis C.
Sovaldi Approved in Japan for Genotype 2 Hepatitis C Treatment
Japanese regulators recently approved the blockbuster hepatitis C drug Sovaldi as the first all-oral treatment regimen for genotype 2 patients in that country.

Most Popular

$vacMongoViewPlus$ $vAR$